Neuralink and Brain-Computer Interface-Exciting Times for Artificial Intelligence.
Purvish Mahendra ParikhAjit VenniyoorPublished in: South Asian journal of cancer (2024)
Purvish Mahendra ParikhBrain-computer interfaces are becoming a tangible reality, capable of significantly aiding patients in real-world scenarios. The recent approval by the U.S. Food and Drug Administration for clinical human trials of Neuralink marks a monumental stride, comparable to Mr. Armstrong's moonwalk. Numerous other companies are also pioneering innovative solutions in this domain. Presently, over 150,000 patients in the United States possess brain implants. As technology advances, it holds the potential to alleviate various conditions, notably motor paralysis, cerebral palsy, and involuntary movements.
Keyphrases
- artificial intelligence
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- cerebral palsy
- drug administration
- endothelial cells
- machine learning
- peritoneal dialysis
- magnetic resonance
- white matter
- magnetic resonance imaging
- multiple sclerosis
- risk assessment
- blood brain barrier
- human health